A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)

Clinical trial NCT02943577 · COMPLETED

Trial details

NCT number: NCT02943577
Sponsor: Naurex, Inc, an affiliate of Allergan plc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2016-11-02
Primary completion: 2018-10-26
Enrollment: 429

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.